1354 Aloha Street
Seattle, WA 98109
855.557.0555
325 9th Avenue
Seattle, WA 98104
206.744.8067
Dr. Yang is the Director of Metastatic Disease and Developmental Therapeutics in the Department of Radiation Oncology at the University of Washington. Dr. Yang specializes in treating metastatic cancer and central nervous system malignancies with advanced radiation techniques including stereotactic radiation therapy and proton therapy, as well as novel and cutting-edge clinical trials.
I believe in understanding the specific needs of patients and providing care that is consistent with their goals. As the complexity of cancer treatments evolves, I am an advocate for my patients. I want patients to feel that, yes we are dealing with a difficult diagnosis, but there are options, and I am here for them and am privileged to be on their team.
College: University of North Carolina-Chapel Hill
Medical Education: Yale University
Doctorate: Vrije Universiteit-Amsterdam
Internship: Memorial Sloan Kettering Cancer Center
Residency: Memorial Sloan Kettering Cancer Center
Biocept CNSide (FORESEE): A Longitudinal Therapy Response Monitoring Study with Leptomeningeal Metastases Using CNSide (CSF Tumor Cells) Compared to Standard of Care (CSF Cytology, Clinical Evaluation, and Imaging)
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
DebioPharm: A Phase 1/2 open-label study of Debio 0123 in combination with temozolomide in adult participants with recurrent or progressive glioblastoma and of Debio 0123 in combination with temozolomide and radiotherapy in adult participants with newly diagnosed glioblastoma
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
Biorepository for Biomarker Development for Brain Tumors
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
A Phase I Study Assessing the Safety and Tolerability of Ascending Doses of AZD1390 in Combination with Stereotactic Body Radiation Therapy (SBRT) in Patients with Metastatic Solid Tumor Malignancies
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
Kazia: A Phase I Study with Expansion Cohort of Concurrent GDC-0084 with Radiation Therapy for Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD